Super Zhewitra Tablets: Composition, Uses and Safety Guide

Super Zhewitra is a combination medicine commonly listed as containing Vardenafil 20 mg and Dapoxetine 60 mg. It is intended to address two male sexual health conditions: erectile dysfunction (ED) and premature ejaculation (PE). Product composition and availability may vary, so always verify the exact ingredients and strengths printed on the product packaging.

Cordium Pharmaceuticals Pvt Ltd. provides product-related information to help readers understand the medicine, its potential uses, and important safety considerations. Super Zhewitra should only be used under appropriate medical supervision and in accordance with applicable local regulations.

Super Zhewitra Tablets: Composition and Uses

The commonly listed formulation contains two active ingredients:

Vardenafil 20 mg: A phosphodiesterase type 5 (PDE5) inhibitor that helps increase blood flow to the penis during sexual stimulation.

Dapoxetine 60 mg: A short-acting selective serotonin reuptake inhibitor (SSRI) used in certain patients to help delay ejaculation.

The combination may be prescribed for eligible adult men experiencing both erectile dysfunction and premature ejaculation. It does not increase sexual desire, prevent sexually transmitted infections, or provide protection against pregnancy.

Potential Benefits of Super Zhewitra Tablets

When prescribed appropriately, Super Zhewitra may offer the following potential benefits:

1. Support for erectile function: Vardenafil may help men with erectile dysfunction achieve and maintain an erection when sexually stimulated.

2. Ejaculation control: Dapoxetine may help eligible patients improve control over ejaculation and increase the time before ejaculation.

3. Combined treatment approach: The two ingredients address different symptoms, potentially making the combination suitable for patients diagnosed with both conditions.

Individual responses vary, and treatment suitability must be determined by a qualified healthcare professional.

Super Zhewitra Tablets Side Effects

Like other prescription medicines, Super Zhewitra may cause side effects. Possible effects include headache, dizziness, flushing, nasal congestion, indigestion, nausea and diarrhoea. Dapoxetine may also cause sleep disturbances, sweating or a drop in blood pressure that can lead to fainting.

Seek urgent medical attention for chest pain, sudden vision or hearing loss, a severe allergic reaction, or an erection lasting four hours or longer.

Important precautions: Do not take Super Zhewitra with nitrate medicines used for chest pain or recreational nitrites (“poppers”), because the combination can cause a dangerous fall in blood pressure. It may also interact with other medicines, including certain antidepressants. Avoid alcohol because it can increase dizziness and fainting risk. Never change the dose or combine treatments without medical advice.

Frequently Asked Questions About Super Zhewitra

1. What is Super Zhewitra used for?

It is commonly listed for treating erectile dysfunction and premature ejaculation in eligible adult men, subject to medical assessment.

2. What are the ingredients in Super Zhewitra?

The commonly listed formulation contains Vardenafil 20 mg and Dapoxetine 60 mg. Confirm the composition on the actual pack.

3. Can Super Zhewitra be taken daily?

The appropriate frequency depends on the prescribed formulation, medical history and local product instructions. Do not take it more frequently than directed by your doctor.

4. What are the common side effects?

Headache, flushing, dizziness, nausea and indigestion are possible. Seek medical advice if symptoms persist or worsen.

5. Is a prescription required?

Super Zhewitra should be treated as a prescription medicine. Consult a qualified healthcare professional before use and follow the medicine regulations applicable in your country.

Medical Disclaimer

This page is for general educational purposes and is not a substitute for professional medical advice. Product information should be verified against the approved packaging and official prescribing information before publication.

Published by Cordium Pharmaceuticals Pvt Ltd.